US Market Overview for Patient Monitoring Equipment 2017 - MedView
The market is segmented into devices pertaining to multi-parameter vital signs monitoring, wireless ambulatory telemetry, telehealth, intracranial pressure monitoring, electromyogram, electroencephalography, cerebral oximetry, fetal and neonatal monitoring, pulse oximetry, cardiac output monitoring and blood pressure monitoring.
Revenue growth since the end of the recession in 2011 has varied across segments; however, the overall market continues to see recovery motivated by the need to replace equipment that had been retained during the economic downturn. Future growth is expected due to the continued expansion of vital sign monitoring in low-acuity areas of hospitals, alternate care and home settings. Furthermore, advancements in device connectivity and interoperability will drive the total market as these improvements will help in stabilizing the price decline across segments. In the case of segments that are matured, and thus heavily reliant upon replacement sales, revenue growth may still be driven by the sales of consumables, which are increasing as a result of growing procedural volumes and increased awareness.
The U.S. market for patient monitoring devices and equipment includes products that are designed to measure and observe changes in vital signs, or the neurological, homodynamic and cardiac functions of a patient. The devices exist within almost all areas of hospitals and alternate care sites and are also used in patient homes. Patient monitoring devices are also used for diagnosing patients with certain health complications, providing alerts and tracking treatments. They are aimed at effectively, accurately and quickly obtaining readings that allow health care professionals to make appropriate decisions for patient care. In many cases, patient monitoring devices play a key role in influencing treatments and patient outcomes.